✦ LIBER ✦

Newer risk markers and surrogate endpoints in atherosclerosis management

✍ Scribed by Christie M. Ballantyne

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

LACK OF CORRELATION AND LOW AGREEMENT OF

✍ Martinez, L.; Miname, M.; Bortolotto, L.; Rochitte, C.; Chacra, A.; Santos, R. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 72 KB

1128-122 Prediction of mortality risk in

✍ Stefan Störk; Richard A Feelders; Annewieke W van den Beld; Steven W Lamberts; H 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Associations of cardiovascular risk fact

✍ Kathleen V. Fitch; Eleni Stavrou; Sara E. Looby; Linda Hemphill; Michael R. Jaff 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 169 KB

Cardiac risk assessment in asymptomatic

✍ Arthur J. H. A. Scholte 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 107 KB

Adiponectin levels, cardiometabolic risk

✍ Pilar Arnaiz; Mónica Acevedo; Salesa Barja; Marlene Aglony; Beatriz Guzmán; Bert 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 138 KB

Surrogate Markers of Atherosclerosis do

✍ A. Ellims; P. Lew; K. Thomson; A. Taylor 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 84 KB